Atlas Trials

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

Clinical trial NCT00114361 · COMPLETED

Trial details

NCT number
NCT00114361
Sponsor
Foundation for Liver Research
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis B
Start date
2005-03-01
Primary completion
2008-05-01
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.